TriSalus Life Sciences, Inc.
TLSI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $12 | $9 | $30 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $5 | $4 | $2 | $1 |
| Inventory | $4 | $3 | $1 | $1 |
| Other Curr. Assets | $3 | $3 | $5 | $2 |
| Total Curr. Assets | $21 | $21 | $17 | $35 |
| Property Plant & Equip (Net) | $3 | $3 | $4 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $1 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $4 | $5 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $24 | $25 | $22 | $38 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $5 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $11 | $27 | $5 |
| Total Curr. Liab. | $10 | $15 | $32 | $6 |
| LT Debt | $23 | $1 | $2 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $16 | $36 | $0 | $1 |
| Total NC Liab. | $40 | $37 | $2 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $0 |
| Total Liabilities | $50 | $52 | $34 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $164 | $161 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$280 | -$250 | -$186 | -$136 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $254 | $222 | $10 | $7 |
| Total Equity | -$26 | -$27 | -$12 | $31 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $24 | $25 | $22 | $38 |
| Net Debt | $15 | -$10 | -$7 | -$30 |